ORIGINAL RESEARCH
Evaluation of Counteraction Potential of ZnO-NPs and/or Piperacillin-Tazobactam against Multi-Drug Resistant Pseudomonas aeruginosa and MCF-7 and HepG2 Cell Lines
 
More details
Hide details
1
General Medicine Department, Fauji Foundation Hospital (FFH), Rawalpindi Pakistan
 
2
National Institute for Genomics and Advanced Biotechnology (NIGAB), National Agriculture Research Centre, Islamabad
 
3
Department of Biosciences, COMSATS University 45500, Islamabad Pakistan
 
4
Boston Children Hospital, Harvard Medical School, 300 Longwood Ave, Boston, MA 02115, USA
 
5
Institute of Biotechnology and Genetic Engineering (IBGE), The University of Agriculture Peshawar, 25130, Pakistan
 
6
Department of Botany, Islamia College Peshawar, 25120, Pakistan
 
7
University Public School, University of Peshawar, 25120 Peshawar, Pakistan
 
8
Department of Zoology, College of Science, King Saud University, Riyadh- 11451, Saudi Arabia
 
9
Department of Crop and Animal production, Sason Vocational School, Batman University, Batman, 72060, Turkey
 
10
Department of Botany, Faculty of Life and Environmental Sciences, University of Peshawar, Peshawar 25120, Pakistan
 
11
Department of Chemistry, Islamia College Peshawar, 25120, Pakistan
 
12
Institute of Industrial Biotechnology, Government College University, Lahore, 54000, Pakistan
 
13
Department of Plant Sciences, Quaid-i-Azam University, Islamabad 45320, Pakistan
 
14
Institute of Biological Sciences, Faculty of Science, Universiti Malaya, Kuala Lumpur 50603, Malaysia
 
 
Submission date: 2023-08-08
 
 
Final revision date: 2023-09-02
 
 
Acceptance date: 2023-09-09
 
 
Online publication date: 2023-11-07
 
 
Publication date: 2024-01-03
 
 
Corresponding author
Sahir Hameed Khattak   

National Institute for Genomics and Advanced Biotechnology (NIGAB), National Agriculture Research Centre, Islamabad
 
 
Muhammad Nauman Khan   

Department of Botany, Bacha Khan University, Charsadda, KP, Pakistan
 
 
Pol. J. Environ. Stud. 2024;33(1):619-629
 
KEYWORDS
TOPICS
ABSTRACT
Nanotechnology offers promising opportunities in combating infectious agents, especially multidrug-resistant bacteria (MDR), which is a major concern in modern times. Zinc oxide nanoparticles (ZnO-NPs) are effective in delivering therapeutic agents to living systems due to their biocompatibility and bioactivity, making them effective against infectious microbes and also allowing them to be applied as an effective anticancer instrument. This study aimed to investigate the antimicrobial activity of ZnO-NPs against P. aeruginosa, a multi-drug resistant (MDR) bacterium in combination with Piperacillin-Tazobactam, as well as the in vitro effect of anticancer activity on MCF-7 and HepG2 cell lines. Piperacillin-Tazobactam, are beta-lactam antibiotics highly effective against Gram-positive and Gram-negative bacteria such as Pseudomonas aeruginosa, and recommended for the empirical treatment of Febrile Neutropenia (FN) after chemotherapy. ZnO-NPs of variable size (designated as ZnO-NPs-A, ZnO-NPs-B, and ZnO-NPs-C with 35±2.5 nm, 50±2 nm, and 65±3 nm mean sizes, respectively) and Piperacillin-Tazobactam alone and in combination were used for the study. The extended-spectrum beta-lactamase (ESBLs) producing MDR P. aeruginosa strain sensitivity profiling towards different combinations of ZnO-NPs and Piperacillin-Tazobactam was measured. There was no synergistic effect observed against growth inhibition of P. aeruginosa. The combined dose of ZnO-NPs-A and Piperacillin-Tazobactam showed great antibacterial efficacy even as compared to the pure drug against P. aeruginosa. Similarly, the Piperacillin-Tazobactam with ZnO-NPs-C showed the least cell viability as compared to the drug alone. The study showed a significant decrease in cell viability with the combined application of Piperacillin-Tazobactam and ZnO-Nps in comparison to the individual treatments.
eISSN:2083-5906
ISSN:1230-1485
Journals System - logo
Scroll to top